Literature DB >> 10495625

[Multiple endocrine neoplasia Type I. Diagnosis and therapy in a case with classical family history].

R Lamberts1, M Gregor.   

Abstract

BACKGROUND: A classical family history, representative of the multiple endocrine neoplasia type I (MEN I) syndrome, is reported to illustrate the clinical manifestations, diagnostic procedures and therapeutic modalities of the various endocrine disorders of this syndrome. DIAGNOSIS: Today genetic analysis clearly identifies gene carriers. In these patients screening of all involved endocrine organs (parathyroid, pituitary, pancreas) at regular time intervals is necessary because also at higher ages additional endocrine manifestations may develop. Due to consequent screening the age at time of diagnosis was reduced by 10 to 20 years. As a consequence the rate of malignancy of pancreatic endocrine tumors which is the limiting factor with regard to long-term prognosis was reduced to about one third. At present it is not known whether this procedure can also increase the survival rate of MEN I patients as could be demonstrated in the MEN II syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10495625     DOI: 10.1007/BF03044730

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  60 in total

1.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

Review 2.  Multiple endocrine neoplasia type I.

Authors:  D C Metz
Journal:  Semin Gastrointest Dis       Date:  1995-04

3.  Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome.

Authors:  C Bordi; A Falchetti; C Azzoni; T D'Adda; A Morelli; A Peracchia; M L Brandi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?

Authors:  G Cadiot; P Laurent-Puig; B Thuille; T Lehy; M Mignon; S Olschwang
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

5.  The Zollinger-Ellison syndrome. A collective surgical experience.

Authors:  D R Farley; J A van Heerden; C S Grant; L J Miller; D M Ilstrup
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

6.  Ultrasonography of the pancreas in patients with multiple endocrine neoplasia type I.

Authors:  P F Davies; J E Shevland; J J Shepherd
Journal:  J Ultrasound Med       Date:  1993-02       Impact factor: 2.153

Review 7.  Multiple endocrine neoplasia type 1. Clinical features and screening.

Authors:  B Skogseid; J Rastad; K Oberg
Journal:  Endocrinol Metab Clin North Am       Date:  1994-03       Impact factor: 4.741

8.  Nonrandom expression of polypeptide hormones in pancreatic endocrine tumors. An immunohistochemical study in a case of multiple islet cell neoplasia.

Authors:  F P Pilato; T D'Adda; E Banchini; C Bordi
Journal:  Cancer       Date:  1988-05-01       Impact factor: 6.860

Review 9.  Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.

Authors:  E Solcia; C Capella; R Fiocca; G Rindi; J Rosai
Journal:  Am J Surg Pathol       Date:  1990-06       Impact factor: 6.394

10.  [Thymus carcinoid in multiple endocrine neoplasms type I].

Authors:  J Zahner; F Borchard; U Schmitz; W Schneider
Journal:  Dtsch Med Wochenschr       Date:  1994-02-04       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.